Furazolidon, tablets 50 mg 20 pcs

Poisoning, Diarrhea, Intestinal infections, Amebiasis and giardiasisIt is prescribed for the treatment of dysentery, paratyphoid, food toxic infections, giardiasis and other diseases caused by microorganisms sensitive to it.

Indications

Prescribed for the treatment of dysentery, paratyphoid, food toxic infections, giardiasis and other diseases caused by microorganisms sensitive to it.

Special instructions

Restricted for use in chronic renal failure and diseases of the nervous system.

Active ingredient

Furazolidone

Composition

one tablet contains the active ingredient: furazolidone – 50 mg; excipients: lactose monohydrate, anhydrous colloidal silicon dioxide, calcium stearate, potato starch.

Contraindications

End-stage chronic renal failure, liver dysfunction, glucose-6-phosphate dehydrogenase deficiency, pregnancy, breastfeeding, children under 8 years of age, increased individual sensitivity to the components of the drug and nitrofurans.

Do not use for urinary tract infections.

Side Effects

In some cases, nausea, vomiting, loss of appetite, and allergic reactions (skin rash, hyperemia and itching of the skin, allergic edema) may occur.

Interaction

Agents that alkalize urine reduce the effect (accelerate excretion in urine), while acidifying agents increase it.

Overdose

Symptoms: acute toxic hepatitis, hematotoxicity, neurotoxicity (polyneuritis).

Storage conditions

In a dry place, protected from light, at a temperature of 5–30 °C

Shelf life

3 years.

Manufacturer

Borisov Medical Preparations Plant, Belarus